In This Issue
- Clinical Trial Spotlight: Dual ABL Inhibition for BCR-ABL Positive Acute Lymphoblastic Leukemia
- Faculty Spotlight: Q&A with Rahul Vedula, MD
- How Venetoclax Is Being Used and Studied in Hematologic Malignancies
- Plans for the New Edward P. Evans Center for Myelodysplastic Syndromes
- Understanding the Impact of Telomere Length and Mutations on Transplant Outcomes
Additional Resources
Adult Leukemia Program
Cellular Therapies Program
Stem Cell Transplantation Program